New Cardiolab ApS: Financial statements 2024
CVR: 36895705
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
New Cardiolab ApS (CVR 36895705) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 1,483,747 and a net result of DKK 1,099,197 compared with DKK -379,151 the year before. That is an increase of 30.1% compared with the year before. Equity in the 2024 report amounted to DKK 224,437. The solvency ratio was 8.3%. The company had 4 employees in the financial year.
- Gross Profit
- DKK 1,483,747
- Profit/Loss
- DKK 1,099,197
- Equity
- DKK 224,437
- Total Assets
- DKK 2,692,031
- Employees
- 4
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 1.5 mio. | 1.1 mio. | 224 t. | 4 |
| 2023 | - | 1.1 mio. | -379 t. | -875 t. | 5 |
| 2022 | - | 1.2 mio. | 180 t. | -496 t. | 5 |
| 2021 | - | 195 t. | 516 t. | -675 t. | 3 |
| 2020 | - | 80 t. | -34 t. | -1.2 mio. | 1 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
New Cardiolab ApS has published its annual report for 2023. Gross profit came to DKK 1,140,118, and the net result was DKK -379,151.
About New Cardiolab ApS
New Cardiolab ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2015. The company is registered under the industry Speciallægers aktiviteter. The management consists of Janet Alsø and Susan Alsø. The company is owned by Susan Alsø Holding ApS and Janet Alsø Holding ApS. The company has 6 employees (2026). In 2025, the company reported a gross profit of DKK 1,878,462 and a net result of DKK 76,064 compared with DKK 1,099,197 the year before. Equity in the 2025 report amounted to DKK 300,501.